Publication Type:

Journal Article

Source:

International Journal of Pharmaceutical Sciences Review and Research, Volume 44, Issue 1, p.27-29 (2017)

URL:

http://globalresearchonline.net/journalcontents/v44-1/07.pdf

Keywords:

Acute cellular Rejection (ACR), Antibody mediated Rejection (AMR)., End stage renal disease (ESRD), Simultaneous pancreas kidney transplantation (SPK), Tacrolimus (TAC)

Abstract:

Simultaneous pancreas kidney transplantation (SPK) performed as the universal treatment for patients who have type 1 diabetes mellitus and ESRD. Here we present a case series of 4 SPK cases, successfully performed. Successful SPK transplantation increase patient survival enhances quality of life, and decline diabetic complications. Suitability of SPK transplantation is dependent upon patient selection including their age and comorbidities. All patients received transplanted organ from cadaveric donor. This article discusses with immunosuppression consists of induction and maintenance therapy. Allograft dysfunction is a serious issue, after transplantation of kidney. Management of ACR and AMR has been discussed in the fourth case.

Cite this Research Publication

D. S. Raju, Sudhindran, S., and Roshni P. R., “A case series on Simultaneous Pancreas Kidney transplantation”, International Journal of Pharmaceutical Sciences Review and Research, vol. 44, no. 1, pp. 27-29, 2017.

207
PROGRAMS
OFFERED
6
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS